Home › Myelofibrosis › Ohio › Cincinnati

Myelofibrosis clinical trials in Cincinnati, OH

5 studies for Myelofibrosis are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

RecruitingPhase 1

University of Cincinnati, Cincinnati

Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06343805

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

RecruitingPhase 1

Cincinnati Children's Hospital Medical Center, Cincinnati
University of Cincinnati, Cincinnati

Ages 13 and older · All sexes · Updated May 5, 2026 · NCT04771572

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study

Massive Bio SYNERGY-AI site, Cincinnati

All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

RecruitingPhase 3

University of Cincinnati Medical Center, Cincinnati

Ages 18 and older · All sexes · Updated Sep 25, 2025 · NCT06479135

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

RecruitingPhase 1/2

University of Cincinnati (UC), Cincinnati

Ages 18 and older · All sexes · Updated Feb 21, 2023 · NCT05280509

Myelofibrosis trials in other cities

Other studies in Cincinnati

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.